n-methyl-3,4-methylenedioxyamphetamine and 6-cyano-7-nitroquinoxaline-2,3-dione

n-methyl-3,4-methylenedioxyamphetamine has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Finnegan, KT; Taraska, T1
Aguilar, MA; García-Pardo, MP; Miñarro, J1

Other Studies

2 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and 6-cyano-7-nitroquinoxaline-2,3-dione

ArticleYear
Effects of glutamate antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine-induced striatal dopamine release in vivo.
    Journal of neurochemistry, 1996, Volume: 66, Issue:5

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amines; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine; Excitatory Amino Acid Antagonists; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pipecolic Acids; Rats; Rats, Sprague-Dawley

1996
Role of AMPA glutamate receptors in the conditioned rewarding effects of MDMA in mice.
    Behavioural brain research, 2018, 07-16, Volume: 347

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amphetamine-Related Disorders; Animals; Conditioning, Psychological; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Hallucinogens; Male; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Receptors, AMPA; Reward; Spatial Behavior

2018